Update in infectious diseases

Annals of Internal Medicine

Volumn 126, Issue 1, 1997, Pages 48-56

  Bartlett, John G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CD4 ANTIGEN; COTRIMOXAZOLE; ERYTHROMYCIN; IMIPENEM; INDINAVIR; INFLUENZA VACCINE; PENICILLIN DERIVATIVE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; TETRACYCLINE; TUBERCULOSTATIC AGENT; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC RESISTANCE; CREUTZFELDT JAKOB DISEASE; EBOLA VIRUS; EPIDEMIC; HERPES VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INFLUENZA VACCINATION; KAPOSI SARCOMA; MORTALITY; MULTIDRUG RESISTANCE; NEEDLESTICK INJURY; OPPORTUNISTIC INFECTION; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STREPTOCOCCUS PNEUMONIAE; TUBERCULOSIS; VIRUS REPLICATION;

EID: 0031025125     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-126-1-199701010-00007     Document Type: Review

References (18)

1. Mullooly JP, Bennett MD, Hornbrook MC, Barker WH, Williams WW, Patriarca PA, et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med. 1994;121:947-52.
2. Pablos-Mendez A, Sterling TR, Frieden TR. The relationship between delayed or incomplete treatment and all-cause mortality in patients with tuberculosis. JAMA. 1996;276:1223-8.
3. Frieden TR, Sherman LF, Maw KL, Fujiwara PI, Crawford JT, Nivin B, et al. A multi-institutional outbreak of highly drug-resistant tuberculosis. Epidemiology and outcomes. JAMA. 1996;276:1229-35.
4. Bass JB Jr, Farer LS, Hopewell PC, O'Brien R, Jacobs RF, Ruben F, et al. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention. Am J Respir Crit Care Med. 1994;149:1359-74.
5. Doern GV, Brueggemann A, Holley HP Jr, Rauch AM. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother. 1996;40: 1208-13.
6. Defining the public health impact of drug-resistant Streptococcus pneumoniae: report of a working group. MMWR Morb Mortal Wkly Rep. 1996; 45(RR-1 Suppl 1):1-20.
7. Butler JC, Hofmann J, Cetron MS, Elliott JA, Facklam RR, Breiman RF, et al. The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's pneumococcal sentinel surveillance system. J Infect Dis. 1996; 174:986-93.
8. Smith PG, Cousens SN. Is the new variant of Creutzfeldt-Jakob disease from mad cows? Science. 1996;273:748.
9. Ho DD. Time to hit HIV, early and hard [Editorial]. N Engl J Med. 1995;333: 450-1.
10. Saag MS, Holodniy M, Kuritzkes DR, O'Brien WA, Coombs R, Poscher ME, et al. HIV viral load markers in clinical practice. Nat Med. 1996;2:625-9.
11. Markowitz M, Saag M, Powderly WG, Hurley AM, Hsu A, Valdes JM, et al. A preliminary study of ritinavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection. N Engl J Med. 1995;333:1534-9.
12. Dickover RE, Garratty EM, Herman SA, Sim MS, Plaeger S, Boyer PJ, et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine on viral load. JAMA. 1996;275:599-605.
13. Levy JA. A new human herpesvirus: KSHV or HHV8? [Comment] Lancet. 1995;346:786.
14. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 1995;332:1186-91.
15. Rady RL, Yen A, Rollefson JL, Orengo I, Bruce S, Hughes TK, et al. Herpesvirus-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients. Lancet. 1995;345:1339-40.
16. Huang YQ, Li JJ, Kaplan MH, Poiesz B, Katabira E, Zhang WC, et al. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet. 1995;345:759-61.
17. Moore RD, Bartlett JB. Combination antiretroviral therapy in HIV infection. Pharmacoeconomics. 1996;10:109-13.
18. Kitahata MM, Koepsell TO, Deyo RA, Maxwell CL, Dodge WT, Wagner EH. Physicians' experience with the acquired immunodeficiency syndrome as a factor in patient's survival. N Engl J Med. 1996;334:701-6.